Eric Hsu

Chief Tech/Sci/R&D Officer at INMED PHARMACEUTICALS INC.

Net worth: 3 $ as of 2026-07-30

56 year

Health Technology

Consumer Services

Profile

Eric C.
Hsu is Senior VP-Pre-Clinical Research & Development at InMed Pharmaceuticals, Inc. since 2018.
Previously, Dr. Hsu was VP-Scientific Affairs, Research & Operations at enGene, Inc. from 2002 to 2018.
Education includes an undergraduate degree from McGill University and a doctorate from the University of Toronto conferred in 1999.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INMED PHARMACEUTICALS INC. 0%	2025-12-18	2 ( 0% )	3 $	2026-07-30

Eric Hsu active positions

Companies	Position	Start
INMED PHARMACEUTICALS INC.	Chief Tech/Sci/R&D Officer	2018-03-12

All active positions of Eric Hsu

Former positions of Eric Hsu

Companies	Position	End
enGene, Inc. enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies	Chief Operating Officer	2017-12-31

See the detail of Eric Hsu's experience

Training of Eric Hsu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eric Hsu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
InMed Pharmaceuticals, Inc. InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases	Health Technology
enGene, Inc. enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies	Health Technology
McGill University McGill University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services